Global Non Invasive Prenatal Testing (NIPT) Market

The global Non Invasive Prenatal Testing (NIPT)Marketwas valued at USD 1.28 billion in 2016 and is projected to reach USD 4.99billion by 2025, growing at a CAGR of 16.32% from 2017 to 2025.
Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening (NIPS) is a new genetic test that uses cell-free circulating fetal DNA in the maternal serum to screen for the more common fetal aneuploidies and other genetic disorders.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 High Risk of Chromosomal Abnormalities With Increasing Maternal Age
1.2 Growing Preference for Non-Invasive Techniques Over Invasive Methods
1.3 Launch of New and Advanced Products
1.4 Improving Reimbursement Scenario for NIPT
1.5 Programs Focusing on Increasing the Awareness of NIPT

2. Market Restraints
2.1 Lack of Skilled Professionals

Market Segmentation:
1. Global Non Invasive Prenatal Testing (NIPT)Market, by End User:
1.1 Diagnostic Laboratories
1.2 Hospitals

2. Global Non Invasive Prenatal Testing (NIPT)Market, by Application:
2.1 Trisomy
2.2 Microdeletion Syndrome
2.3 Other Applications

3. Global Non Invasive Prenatal Testing (NIPT)Market, by Method:
3.1 Ultrasound Detection
3.2 Biochemical Screening Tests
3.3 Cell-Free Dna in Maternal Plasma Tests
3.4 Fetal Cells in Maternal Blood Tests

4. Global Non Invasive Prenatal Testing (NIPT) Market, by Product:
4.1 Consumables
4.1.1 Assay Kits & Reagents
4.1.2 Disposables
4.2 Instruments
4.2.1 Ultrasound Devices
4.2.2 Next-Generation Sequencing Systems
4.2.3 Polymerase Chain Reaction Instruments
4.2.4 Microarrays
4.2.5 Other Instruments

5. Global Non Invasive Prenatal Testing (NIPT) Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Ge Healthcare (A Wholly Owned Subsidiary of General Electric Company)
2. Koninklijke Philips N.V.
3. Illumina, Inc.
4. Thermo Fisher Scientific, Inc.
5. F. Hoffman-La Roche Ltd.
6. Pacific Biosciences of California, Inc.
7. Perkinelmer, Inc.
8. Qiagen N.V.
9. Agilent Technologies, Inc.
10. Beijing Genomics Institute
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Non Invasive Prenatal Testing (NIPT)Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.